The COVID-19 pandemic has changed the way health care is routinely delivered,with pharmacists taking a lead role in meeting individual patient needs across practice settings. This article will discuss CMS’s updated telehealth regulations during the COVID-19 pandemic and telehealth implementation considerations for pharmacists, and review COVID-19 testing models, diagnostic tests, and a pharmacy-led COVID-19 testing service. And consider clinical considerations for administration, and key counseling pearls rekated to two currently available COVID-19 vaccinations,
At the completion of this activity, pharmacists will be able to:
- Describe CMS's updated telehealth regulations during the COVID-19 pandemic and telehealth implementation considerations for pharmacists.
- Summarize COVID-19 testing models, characteristics of approved diagnostic tests, and practical considerations for establishing a pharmacy-led COVID-19 testing service.
- State the characteristics of the two currently available COVID-19 vaccinations, clinical considerations for administration, and key counseling pearls.
Activity Type: Knowledge-based
Target Audience: Pharmacists
Learning Level: 1
The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hours of CPE credit (0.10 CEUs). The ACPE Universal Activity Number for this activity is 0202-0000-21-143-H04-P.
To obtain credit for Pharmacists' Role During the COVID-19 Pandemic, complete the assessment with a grade of 70% or better, complete the evaluation, and then claim credit. Participants need to have a valid pharmacist.com username and password to claim credit. After credit has been claimed, please visit CPE monitor for your transcript.
APhA's continuing pharmacy education policy allows two opportunities to successfully complete the continuing pharmacy education assessment. Please note that the questions may not appear in the same order as printed and only two attempts to pass the assessment will be granted. The current policy of the APhA Education Department is to not release the correct answers to any of our CPE tests. This policy is intended to maintain the integrity of the CPE activity and the assessment.
Initial release date: March 1, 2021
Expiration date: March 1, 2024 - No credit can be earned after this date
Pharmacists' Role During the COVID-19 Pandemic, is a home-study continuing education activity for pharmacists developed by the American Pharmacists Association. © 2021 American Pharmacists Association
Maria G. Tanzi, PharmD, adjunct assistant professor, Department of Pharmaceutical Sciences, University of Illinois at Chicago College of Pharmacy; and associate director, Incyte Corporation
Maria G. Tanzi, PharmD and APhA editorial staff declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For complete staff disclosures, please see the Education and Accreditation Information section at www.pharmacist.com/apha-disclosures.
There is no fee associated with this activity for members of the American Pharmacists Association. There is a $25 fee for nonmembers.
Computer and internet access are required to complete this activity. Please visit our website to view the Technology System Requirements in order to have a positive learning experience.
|Activity Number||Credit Amount||Accreditation Period|
|ACPE# 0202-0000-21-143-H04-P||0.1 CEUs||March 01, 2021 - March 01, 2024|